Undetermined Cause of Cardiac Arrest during Hemodialysis — Connecticut 2015-2016

ICR 201601-0920-014

OMB: 0920-1095

Federal Form Document

ICR Details
0920-1095 201601-0920-014
Historical Active
HHS/CDC 0920-16
Undetermined Cause of Cardiac Arrest during Hemodialysis — Connecticut 2015-2016
New collection (Request for a new OMB Control Number)   No
Emergency 01/27/2016
Approved without change 01/27/2016
Retrieve Notice of Action (NOA) 01/27/2016
CDC will submit an extension or revision if it is anticipated that this collection will continue for longer than six months. That decision must be made within two months before the expiration in order to leave sufficient time to prepare the package in an orderly fashion.
  Inventory as of this Action Requested Previously Approved
07/31/2016 6 Months From Approved
114 0 0
57 0 0
0 0 0

Seven patients in Connecticut have experienced sudden and unexpected cardiovascular collapse leading to cardiac arrest during routine outpatient hemodialysis since December 18, 2015. Three of the affected patients had evidence suggesting an anaphylactic reaction; all three of these patients died. Five of these events occurred in a single clinic and the remaining two events were in two nearby dialysis clinics owned by the same company. CDC is currently conducting an Epi-Aid to support the Connecticut Department of Public Health (CT DPH) with their investigation of these events. Because these events could be linked to a healthcare product (e.g., medical device or pharmaceutical) with widespread distribution, broad case-finding efforts are needed. CDC has determined that this information must be collected prior to the expiration of time period established under Part 1320, and that this information is essential to the CDC’s ability to identify a cause of these events and prevent additional events from occurring.
Seven patients in Connecticut have experienced sudden and unexpected cardiovascular collapse leading to cardiac arrest during routine outpatient hemodialysis since December 18, 2015. Three of the affected patients had evidence suggesting an anaphylactic reaction; all three of these patients died. Five of these events occurred in a single clinic and the remaining two events were in two nearby dialysis clinics owned by the same company. CDC is currently conducting an Epi-Aid to support the Connecticut Department of Public Health (CT DPH) with their investigation of these events. Because these events could be linked to a healthcare product (e.g., medical device or pharmaceutical) with widespread distribution, broad case-finding efforts are needed. CDC has determined that this information must be collected prior to the expiration of time period established under Part 1320, and that this information is essential to the CDC’s ability to identify a cause of these events and prevent additional events from occurring.

US Code: 42 USC 241 Name of Law: PHSA
  
None

Not associated with rulemaking

No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 114 0 0 114 0 0
Annual Time Burden (Hours) 57 0 0 57 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
Submission is a New Emergency ICR

$26,329
No
No
No
No
No
Uncollected
Jeffrey Zirger 404 639-7118 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/27/2016


© 2024 OMB.report | Privacy Policy